These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25758914)

  • 1. Desensitization to febuxostat: report of two cases.
    Di Paolo C; Minetti S; Mineni M; Inverardi S; Rizzini FL; Cinquini M; Tosoni C
    J Allergy Clin Immunol Pract; 2015; 3(4):633-6. PubMed ID: 25758914
    [No Abstract]   [Full Text] [Related]  

  • 2. [Febuxostat or allopurinol in patients with gout : Cardiovascular Safety of Febuxostat and Allopurinol in Patients with Gout and Cardiovascular Morbidities (CARES)].
    Alten R; Mischkewitz M; Nitschmann S
    Internist (Berl); 2020 May; 61(5):530-532. PubMed ID: 32130437
    [No Abstract]   [Full Text] [Related]  

  • 3. Gout Medication Receives Black Box Warning.
    Aschenbrenner DS
    Am J Nurs; 2019 Jun; 119(6):24-25. PubMed ID: 31135425
    [No Abstract]   [Full Text] [Related]  

  • 4. Febuxostat for the chronic management of hyperuricemia in patients with gout.
    Chinchilla SP; Urionaguena I; Perez-Ruiz F
    Expert Rev Clin Pharmacol; 2016; 9(5):665-73. PubMed ID: 26942273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Febuxostat hypersensitivity.
    Abeles AM
    J Rheumatol; 2012 Mar; 39(3):659. PubMed ID: 22383358
    [No Abstract]   [Full Text] [Related]  

  • 6. A word of caution regarding Febuxostat.
    Ochani RK; Yasmin F; Batra S; Asad A
    J Pak Med Assoc; 2019 Dec; 69(12):1930. PubMed ID: 31853136
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful Desensitization to Febuxostat in a Patient With Hypersensitivity to Allopurinol and Febuxostat and Review of the Literature.
    Koenig D; Royer C; Azar A
    J Clin Rheumatol; 2021 Dec; 27(8S):S432-S433. PubMed ID: 31977653
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk of Heart-Related Death From Gout Medication.
    Aschenbrenner DS
    Am J Nurs; 2018 Mar; 118(3):23. PubMed ID: 29470212
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk of cutaneous adverse events with febuxostat treatment in patients with skin reaction to allopurinol. A retrospective, hospital-based study of 101 patients with consecutive allopurinol and febuxostat treatment.
    Bardin T; Chalès G; Pascart T; Flipo RM; Korng Ea H; Roujeau JC; Delayen A; Clerson P
    Joint Bone Spine; 2016 May; 83(3):314-7. PubMed ID: 26709250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discontinuing febuxostat might cause more deaths than continuing febuxostat: the untold story from the CARES trial.
    Ghang B; Ahn SM; Kim J; Kim YG; Lee CK; Yoo B
    Rheumatology (Oxford); 2020 Jun; 59(6):1439-1440. PubMed ID: 31748801
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral desensitization in patients with chronic tophaceous gout and allopurinol hypersensitivity.
    Gillott TJ; Whallett A; Zaphiropoulos G
    Rheumatology (Oxford); 1999 Jan; 38(1):85-6. PubMed ID: 10334688
    [No Abstract]   [Full Text] [Related]  

  • 12. Cross-Reactions Between Allopurinol and Febuxostat.
    Lien YH; Logan JL
    Am J Med; 2017 Feb; 130(2):e67-e68. PubMed ID: 27667702
    [No Abstract]   [Full Text] [Related]  

  • 13. Advances in Urate-Lowering Therapy: Time to Revisit High-Dose Febuxostat.
    Abeles AM
    Am J Ther; 2017 May; 24(3):e241-e242. PubMed ID: 28291044
    [No Abstract]   [Full Text] [Related]  

  • 14. Febuxostat-induced agranulocytosis in an end-stage renal disease patient: A case report.
    Poh XE; Lee CT; Pei SN
    Medicine (Baltimore); 2017 Jan; 96(2):e5863. PubMed ID: 28079821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Febuxostat (Uloric) for chronic treatment of gout.
    Med Lett Drugs Ther; 2009 May; 51(1312):37-8. PubMed ID: 19448587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Febuxostat provides new gout treatment option.
    Belavic JM
    Nurse Pract; 2010 Mar; 35(3):9-10. PubMed ID: 20164728
    [No Abstract]   [Full Text] [Related]  

  • 17. How should hyperuricemia be treated in a patient with allopurinol hypersensitivity?
    Monev SD
    Cleve Clin J Med; 2001 Jul; 68(7):597-8. PubMed ID: 11453075
    [No Abstract]   [Full Text] [Related]  

  • 18. In older adults, new use of allopurinol or febuxostat was linked to hypersensitivity reactions versus colchicine.
    Schattner A
    Ann Intern Med; 2020 Jul; 173(2):JC10. PubMed ID: 32687746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Febuxostat-associated eosinophilic polymyositis in marginal zone lymphoma.
    Chahine G; Saleh K; Ghorra C; Khoury N; Khalife N; Fayad F
    Joint Bone Spine; 2017 Mar; 84(2):221-223. PubMed ID: 27955822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fixed drug eruption-like macules caused by febuxostat.
    Oda T; Sawada Y; Ohmori S; Omoto D; Haruyama S; Yoshioka M; Nishio D; Nakamura M
    Eur J Dermatol; 2016 Aug; 26(4):412-3. PubMed ID: 27211520
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.